Semaglutide Linked to 21% Lower Psychiatric Hospitalization Risk for Bipolar Disorder
Semaglutide, the active pharmaceutical ingredient in medications Ozempic and Wegovy, is linked to a 21% lower risk of psychiatric hospitalization among patients with bipolar disorder, according to a large-scale Swedish ... Read More